How have BXRX shares performed in 2024?

Baudax Bio's stock was trading at $0.0220 at the start of the year. Since then, BXRX stock has decreased by 0.9% and is now trading at $0.0218. View the best growth stocks for 2024 here .

When is Baudax Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our BXRX earnings forecast .

How were Baudax Bio's earnings last quarter?

Baudax Bio, Inc. (NASDAQ:BXRX) issued its quarterly earnings data on Wednesday, August, 16th. The company reported ($1.49) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.55.

When did Baudax Bio's stock split?

Baudax Bio's stock reverse split on the morning of Wednesday, November 30th 2022. The 1-40 reverse split was announced on Wednesday, November 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Baudax Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baudax Bio investors own include Sorrento Therapeutics (SRNE) , Coty (COTY) , NIO (NIO) , VBI Vaccines (VBIV) , ADMA Biologics (ADMA) , Energy Transfer (ET) , Remark (MARK) , Designer Brands (DBI) , Geron (GERN) and Matinas BioPharma (MTNB) .

How do I buy shares of Baudax Bio?

Shares of BXRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BXRX

Baudax Bio (BXRX) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free BXRX Stock Alerts

$0.02

+0.00 (+7.39%)

(As of 02/29/2024)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.02
▼
$0.03
52-Week Range: $0.01
▼
$3.47

Volume: 310,800 shs
Average Volume: 281,029 shs
Market Capitalization: $1.14 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Baudax Bio alerts:

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

About Baudax Bio Stock (NASDAQ:BXRX)

Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care related settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with other non-NSAID analgesics. It also develops BX1000, an intermediate-acting neuromuscular blocking agent (NMB) that is in phase II clinical trial; BX2000, an ultra- short acting NMB, which is in phase I clinical trial, as well as a proprietary blockade reversal agent; and BX3000, a NMB reversal agent that is in preclinical studies. Baudax Bio, Inc. was incorporated in 2019 and is based in Malvern, Pennsylvania.

BXRX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BXRX Stock News Headlines

April 8, 2024 | americanbankingnews.com

Baudax Bio (NASDAQ:BXRX) versus Travere Therapeutics (NASDAQ:TVTX) Head-To-Head Review

October 18, 2023 | finance.yahoo.com

Baudax Bio Announces Corporate Update

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

October 2, 2023 | msn.com

Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag

September 28, 2023 | investorplace.com

Why Is Baudax Bio (BXRX) Stock Up 75% Today?

September 28, 2023 | marketwatch.com

Baudax Bio Shares Double After Orphan Drug Designation for TI-168

September 28, 2023 | markets.businessinsider.com

Baudax Bio: FDA Grants Orphan Drug Designation To TI-168 For Hemophilia A With Inhibitors

September 18, 2023 | finance.yahoo.com

Here's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock Now

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

September 7, 2023 | finance.yahoo.com

Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference

August 23, 2023 | finance.yahoo.com

Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock

August 17, 2023 | finance.yahoo.com

Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

August 16, 2023 | finance.yahoo.com

Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

June 30, 2023 | investorplace.com

Why Is Baudax Bio (BXRX) Stock Up 130% Today?

June 8, 2023 | markets.businessinsider.com

Baudax Bio (BXRX) Gets a Hold from Noble Financial

May 22, 2023 | markets.businessinsider.com

Noble Financial Sticks to Their Hold Rating for Baudax Bio (BXRX)

May 15, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Cocrystal Pharma (COCP) and Baudax Bio (BXRX)

May 12, 2023 | finanznachrichten.de

Baudax Bio, Inc.: Baudax Bio Reports First Quarter Financial Results and Provides Business Update

May 12, 2023 | baystreet.ca

Baudax Improves on Q1 Results

May 12, 2023 | msn.com

Recap: Baudax Bio Q1 Earnings

May 12, 2023 | finance.yahoo.com

Baudax Bio Reports First Quarter Financial Results and Provides Business Update

May 3, 2023 | finance.yahoo.com

Baudax Bio to Present at the Sidoti Virtual Investor Conference

May 1, 2023 | finance.yahoo.com

Baudax Bio Announces Closing of $4 Million Public Offering

April 27, 2023 | msn.com

Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

April 27, 2023 | investorplace.com

Why Is Baudax Bio (BXRX) Stock Down 52% Today?

April 27, 2023 | finance.yahoo.com

Baudax Bio Announces Pricing of $4 Million Public Offering

April 25, 2023 | msn.com

Baudax Bio Soars after Positive Topline Data

See More Headlines

Receive BXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/16/2023
Today: 4/18/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:BXRX
CUSIP: N/A
CIK: 1780097
Web: www.baudaxbio.com
Phone: 484-395-2440
Fax: 484-395-2471
Employees: 9
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($9.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-58,790,000.00
Net Margins: N/A
Pretax Margin: -18,950.64%
Return on Equity: N/A
Return on Assets: -175.11%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.07
Quick Ratio: 0.07

Sales & Book Value

Annual Sales: $1.27 million
Price / Sales: 0.90
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($14.93) per share
Price / Book: 0.00

Miscellaneous

Outstanding Shares: 52,460,000
Free Float: 52,408,000
Market Cap: $1.14 million
Optionable: Not Optionable
Beta: 1.57

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Dr. Geraldine A. Henwood Ph.D. (Age 72)
President, CEO & Director
Comp: $633.25k
Mike Choi
Vice President of Financial Planning & Analysis
Ms. Natalie McAndrew (Age 53)
Consultant & Principle Accounting Officer
Dr. Chan Kim Yong Ph.D. (Age 50)
Chief Scientific Officer & Director

Key Competitors

View All Competitors

BXRX Stock Analysis - Frequently Asked Questions

How have BXRX shares performed in 2024?: Baudax Bio's stock was trading at $0.0220 at the start of the year. Since then, BXRX stock has decreased by 0.9% and is now trading at $0.0218.
View the best growth stocks for 2024 here.
When is Baudax Bio's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our BXRX earnings forecast.
How were Baudax Bio's earnings last quarter?: Baudax Bio, Inc. (NASDAQ:BXRX) issued its quarterly earnings data on Wednesday, August, 16th. The company reported ($1.49) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.55.
When did Baudax Bio's stock split?: Baudax Bio's stock reverse split on the morning of Wednesday, November 30th 2022. The 1-40 reverse split was announced on Wednesday, November 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Baudax Bio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Baudax Bio investors own include Sorrento Therapeutics (SRNE), Coty (COTY), NIO (NIO), VBI Vaccines (VBIV), ADMA Biologics (ADMA), Energy Transfer (ET), Remark (MARK), Designer Brands (DBI), Geron (GERN) and Matinas BioPharma (MTNB).
How do I buy shares of Baudax Bio?: Shares of BXRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BXRX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Baudax Bio (BXRX) Stock Price, News & Analysis

About Baudax Bio Stock (NASDAQ:BXRX)

BXRX Stock Price History

BXRX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BXRX Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info